Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Radiology Benefits Manager Welcomes Imaging E-Support Demo

This article was originally published in The Gray Sheet

Executive Summary

The radiology benefits manager business model will be validated once CMS has a chance to review pure-play electronic-decision-support tools that assist doctor decisions on ordering advanced imaging, argues Michael Pentecost, associate chief medical officer for National Imaging Associates, an RBM

You may also be interested in...



Coalition: Out With Radiology Benefits Managers, In With E-Support

The Imaging e-Ordering Coalition hopes to convince government and private payers that electronic decision support tools for providers offer a more cost-effective means of curbing the overuse of high-tech medical imaging than third-party radiology benefits managers

Obama Budget Seeks Prior Authorization For Medicare Imaging

President Obama's budget proposal for fiscal year 2010 includes a plan for Medicare to contract with private third parties to pre-review and approve imaging payments on a scan-by-scan basis

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028447

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel